415
Views
32
CrossRef citations to date
0
Altmetric
Brief Report

Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration

, PhD ORCID Icon, , PhD, , PharmD, , PharmD & , MD, MPH ORCID Icon
Pages 286-288 | Received 27 Jul 2018, Accepted 31 Jul 2018, Published online: 16 Oct 2018

References

  • Wyse JJ, Gordon AJ, Dobscha SK, et al. Medications for opioid use disorder in the department of Veterans Affairs (VA) health care system: historical perspective, lessons learned and next steps. Sub Abuse 2018; epub ahead of print.
  • Bohnert AS, Ilgen MA, Galea S, et al. Accidental poisoning mortality among patients in the Department of Veterans Affairs Health System. Medical Care. 2011;49(4):393–396.
  • The Management of Substance Use Disorders Work Group. Department of Veterans Affairs and Department of Defense Clinical Practice Guideline for the Management of Substance Use Disorders. 2015. Retrieved from: https://www.healthquality.va.gov/guidelines/MH/sud/VADODSUDCPGRevised22216.pdf
  • Oliva E, Trafton J, Harris AHS, et al. Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand? Am J Drug Alcohol Abuse. 2013;39(2):103–107.
  • Stein BD, Sorbero M, Dick AW, et al. Physician capacity to treat opioid use disorder with buprenorphine-assisted treatment. JAMA. 2016;316(11):1211–1212.
  • Thomas CP, Doyle E, Kreiner PW, et al. Prescribing patterns of buprenorphine waivered physicians. Drug Alcohol Depend. 2017;181:213–218.
  • Gordon AJ, Kavanagh G, Krumm M, et al. Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration. Psychology of Addictive Behaviors. 2011;25(2):215–224.
  • Wakeman SE, Barnett ML. Primary Care and the opioid-overdose crisis—buprenorphine myths and realities. New Eng J Med. 2018;379(1):1–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.